IVF and Genetic Center

Name :

IVF and Genetic Center

Address  :

1st Floor, Deshbandhu Complex
Naudra Bridge

Town  :

Jabalpur

State  :

Madhya Pradesh

Country  :

INDIA

Post Code:

482001

Phone  :

91 761 2627711

Web URL  :

Specialization
  • Gynaecology
Facilities

Other Facilities

  • Pathology

Description

About Us
We are two persons working at Ideal Fertility as specialist with dedicated nursing staff

DrDPankar Banerji a qualified Gynecologist working as Infertility Specialist and doing ConsultaionsDownregulation of the patients for IVFICSI Ultrasound scans Interventional sonography egg pickups and embryo transfer

DrMrs Rinku Banerji a qualified pathologist working as a dedicated embryologist and doing Egg handling IVF and ICSI procedures in lab sperm processing sperm and embryo freezing

We provide all required services under one roof for IVF and ICSI cycles You dont have to run at various places for scanning lab tests pickup and embryo transfer There are no other specialists involved in fertility care except DrDPankar Banerji who prepares the patients for IVF and does the oocyte pickup and embryo transfer and DrMrsRinku Banerji as an embryologist We both are always available for our patients through out the year and directly interact with the infertile couples for their counseling and answering their different queries

As we are self sufficient hence our charges for IVF and ICSI are very low compared to other fertility centers We do a package deal for whole cycle and there is no hidden costs like lab chargesconsultationsblood tests etc Cost of one IVF cycle at our clinic is US 1700 and a cycle for IVF with ICSI costs US 2000
Budget hospitals are here to stay Devi Prasad Shetty Narayana Hrudayalaya

Devi Prasad Shetty cardiac surgeon and founder of Narayana Hrudayalaya is all set to replicate the lowcost highvolume model of healthcare that he pioneered across India and overseas The multispecialty hospital chain Narayana Hrudayalaya that he founded will expand its Indian footprint with six new hospitals in the coming year Shetty spoke to Peerza... Read More

Group B Neisseria meningitidis Vaccine Shows Promise

An investigational vaccine may represent a strong lead in the fight against group B Neisseria meningitidis according to results of a phase 2 study published online in the Lancet Administered in 3 doses over the course of 6 months a new bivalent vaccine was well tolerated and induced a strong immune response against multiple strains of the poten... Read More